Scholarlink

Background <p>Symptomatic intracranial atherosclerotic stenosis is a common cause of ischemic stroke, with high recurrence rates despite medical management. The present study investigated the short-term and long-term outcomes of endovascular therapy (ET) versus conventional medical therapy (CMT) in intracranial atherosclerotic stenosis (sICAS) management.</p> Methods <p>We conducted a systematic review and meta-analysis. Searches were performed in PubMed (MEDLINE), Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science (WOS), SCOPUS, and Embase. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. PROSPERO ID: (<i>CRD42024601551</i>).</p> Results <p>Five RCTs involving 1,531 patients were included, with 743 in the ET + CMT group and 748 in the CMT group. ET was associated with increased odds of short-term mortality or stroke (OR, 3.19; 95% CI [1.96, 5.19], <i>P</i> &lt; 0.01), including higher risks of mortality (OR, 4.35; 95% CI [1.23, 15.35], <i>P</i> = 0.02), ischemic stroke (OR, 2.26; 95% CI [1.34, 3.82], <i>P</i> &lt; 0.01), and hemorrhagic stroke (OR, 10.74; 95% CI [2.52, 45.90], <i>P</i> &lt; 0.01), but no difference between both groups in transient ischemic attack (OR, 0.87; 95% CI [0.32, 2.34], <i>P</i> = 0.78). For long-term outcomes, no significant differences were observed. However, ET significantly increased long-term hemorrhagic stroke risk (OR, 5.14; 95% CI [1.48, 17.77], <i>P</i> &lt; 0.01).</p> Conclusion <p>In patients with ischemic stroke due to sICAS, ET plus CMT has increased the risk of all-cause mortality, ischemic stroke, and hemorrhagic stroke compared to CMT alone. Hence, current evidence does not support adjuvant ET for patients with sICAS.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Endovascular therapy vs. conventional medical treatment for symptomatic intracranial atherosclerotic stenosis: an updated meta-analysis of randomized controlled trials

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月20日

查看全文
  • Husam Abu Suilik,
  • Mohammed Baker,
  • Ahmed Naeem,
  • AlMothana Manasrah,
  • Mohamed Elnady,
  • Bashar M. Al Zoubi,
  • Mohamed Abouzid,
  • Mohamed Abuelazm

摘要

Background

Symptomatic intracranial atherosclerotic stenosis is a common cause of ischemic stroke, with high recurrence rates despite medical management. The present study investigated the short-term and long-term outcomes of endovascular therapy (ET) versus conventional medical therapy (CMT) in intracranial atherosclerotic stenosis (sICAS) management.

Methods

We conducted a systematic review and meta-analysis. Searches were performed in PubMed (MEDLINE), Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science (WOS), SCOPUS, and Embase. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. PROSPERO ID: (CRD42024601551).

Results

Five RCTs involving 1,531 patients were included, with 743 in the ET + CMT group and 748 in the CMT group. ET was associated with increased odds of short-term mortality or stroke (OR, 3.19; 95% CI [1.96, 5.19], P < 0.01), including higher risks of mortality (OR, 4.35; 95% CI [1.23, 15.35], P = 0.02), ischemic stroke (OR, 2.26; 95% CI [1.34, 3.82], P < 0.01), and hemorrhagic stroke (OR, 10.74; 95% CI [2.52, 45.90], P < 0.01), but no difference between both groups in transient ischemic attack (OR, 0.87; 95% CI [0.32, 2.34], P = 0.78). For long-term outcomes, no significant differences were observed. However, ET significantly increased long-term hemorrhagic stroke risk (OR, 5.14; 95% CI [1.48, 17.77], P < 0.01).

Conclusion

In patients with ischemic stroke due to sICAS, ET plus CMT has increased the risk of all-cause mortality, ischemic stroke, and hemorrhagic stroke compared to CMT alone. Hence, current evidence does not support adjuvant ET for patients with sICAS.